Medtronic's most recent trend suggests a bullish bias. One trading opportunity on Medtronic is a Bull Put Spread using a strike $55.00 short put and a strike $50.00 long put offers a potential 6.38% return on risk over the next 29 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $55.00 by expiration. The full premium credit of $0.30 would be kept by the premium seller. The risk of $4.70 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Medtronic is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Medtronic is bullish.
The RSI indicator is at 72.88 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Medtronic
Medtronic: A Shining Pharma Investment
Fri, 18 Oct 2013 20:58:35 GMT
Seeking Alpha – Recently, Medtronic ( MDT ) received FDA approval for its innovative artificial pancreas, which automatically regulates insulin delivery for Type-1 diabetes patients. The device is already available in …
Founder of St. Jude Medical to Keynote RedChip Emerging Growth Showcase on Oct. 23-24
Fri, 18 Oct 2013 17:01:03 GMT
GlobeNewswire – ORLANDO, Fla. — RedChip Companies, Inc. (“RedChip”), an international small-cap research, investor relations, and media company, today announced that Manny Villafana, chairman and CEO of biotechnology …
RedChip Announces Presentation Schedule for Oct. 23-24 Emerging Growth Showcase
Fri, 18 Oct 2013 16:52:32 GMT
GlobeNewswire – ORLANDO, Fla. — RedChip Companies, Inc. (“RedChip”), an international small-cap research, investor relations, and media company, today announced that Manny Villafana, chairman and CEO of biotechnology …
Manny Villafana, St. Jude Medical's Founder, to Keynote RedChip Emerging Growth Showcase
Fri, 18 Oct 2013 16:50:00 GMT
GlobeNewswire – ORLANDO, Fla. — RedChip Companies, Inc. (“RedChip”), an international small-cap research, investor relations, and media company, today announced that Manny Villafana, chairman and CEO of biotechnology …
A Compulsion For Brain Science: Zack Lynch
Fri, 18 Oct 2013 13:43:58 GMT
Seeking Alpha – Roughly a third of the world's population feels the burden of some type of brain, spinal cord or peripheral nerve disease: dementia, depression, compulsion, infection, trauma. Understanding the need for …
Related Posts
Also on Market Tamer…
Follow Us on Facebook